| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | neuromuscular junction | 1.61e-04 | 112 | 51 | 4 | GO:0031594 | |
| Domain | ZnF_C3H1 | 7.04e-03 | 48 | 49 | 2 | SM00356 | |
| Domain | WD40_repeat_dom | 7.57e-03 | 297 | 49 | 4 | IPR017986 | |
| Domain | BTB_2 | 8.53e-03 | 53 | 49 | 2 | PF02214 | |
| Domain | T1-type_BTB | 8.53e-03 | 53 | 49 | 2 | IPR003131 | |
| Domain | Znf_CCCH | 1.02e-02 | 58 | 49 | 2 | IPR000571 | |
| Domain | ZF_C3H1 | 1.02e-02 | 58 | 49 | 2 | PS50103 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZC3H14 NCOA6 ZNF609 MAP7D3 PNN CD2AP MDC1 HMGXB4 SAFB2 SLX4IP CHD4 ZC3H18 TOR1AIP1 SON | 8.34e-11 | 954 | 52 | 14 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZC3H14 NCOA6 ZNF609 MAP7D3 PNN MDC1 HMGXB4 SAFB2 CHD4 ZC3H18 NKTR TOR1AIP1 DMAP1 SON | 4.28e-09 | 1294 | 52 | 14 | 30804502 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.43e-08 | 430 | 52 | 9 | 35044719 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.91e-07 | 774 | 52 | 10 | 15302935 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.10e-06 | 361 | 52 | 7 | 26167880 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.27e-06 | 231 | 52 | 6 | 16452087 | |
| Pubmed | 1.50e-06 | 549 | 52 | 8 | 38280479 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.52e-06 | 130 | 52 | 5 | 35545047 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.88e-06 | 148 | 52 | 5 | 32538781 | |
| Pubmed | 2.99e-06 | 268 | 52 | 6 | 33640491 | ||
| Pubmed | 4.16e-06 | 847 | 52 | 9 | 35850772 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.57e-06 | 857 | 52 | 9 | 25609649 | |
| Pubmed | 5.32e-06 | 652 | 52 | 8 | 31180492 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18785023 | ||
| Pubmed | NCOA6 ZNF609 TCF12 PNN MDC1 UBR4 HMGXB4 SLX4IP ZC3H18 DMAP1 FOXI1 | 6.94e-06 | 1429 | 52 | 11 | 35140242 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 9.13e-06 | 934 | 52 | 9 | 33916271 | |
| Pubmed | 9.25e-06 | 188 | 52 | 5 | 29721183 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 9.83e-06 | 330 | 52 | 6 | 33301849 | |
| Pubmed | 1.31e-05 | 347 | 52 | 6 | 17114649 | ||
| Pubmed | The chromatin remodeler Mi-2beta is required for CD4 expression and T cell development. | 1.31e-05 | 4 | 52 | 2 | 15189737 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.56e-05 | 358 | 52 | 6 | 32460013 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.60e-05 | 759 | 52 | 8 | 35915203 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.63e-05 | 361 | 52 | 6 | 30344098 | |
| Pubmed | 1.75e-05 | 1014 | 52 | 9 | 32416067 | ||
| Pubmed | 2.65e-05 | 234 | 52 | 5 | 36243803 | ||
| Pubmed | Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. | 3.28e-05 | 6 | 52 | 2 | 1922066 | |
| Pubmed | 3.47e-05 | 42 | 52 | 3 | 35705031 | ||
| Pubmed | 3.71e-05 | 1116 | 52 | 9 | 31753913 | ||
| Pubmed | 4.00e-05 | 255 | 52 | 5 | 15324660 | ||
| Pubmed | 4.69e-05 | 1442 | 52 | 10 | 35575683 | ||
| Pubmed | 5.12e-05 | 653 | 52 | 7 | 22586326 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 5.19e-05 | 444 | 52 | 6 | 34795231 | |
| Pubmed | 6.06e-05 | 916 | 52 | 8 | 32203420 | ||
| Pubmed | 7.17e-05 | 689 | 52 | 7 | 36543142 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 7.66e-05 | 150 | 52 | 4 | 28242625 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 7.75e-05 | 949 | 52 | 8 | 36574265 | |
| Pubmed | Switching of α-Catenin From Epithelial to Neuronal Type During Lens Epithelial Cell Differentiation. | 7.84e-05 | 9 | 52 | 2 | 28692740 | |
| Pubmed | 8.58e-05 | 963 | 52 | 8 | 28671696 | ||
| Pubmed | 8.87e-05 | 713 | 52 | 7 | 29802200 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 9.14e-05 | 157 | 52 | 4 | 30686591 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 9.60e-05 | 307 | 52 | 5 | 37499664 | |
| Pubmed | 9.64e-05 | 497 | 52 | 6 | 23414517 | ||
| Pubmed | Identification of a Nuclear Exosome Decay Pathway for Processed Transcripts. | 9.79e-05 | 10 | 52 | 2 | 27871484 | |
| Pubmed | Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. | 1.20e-04 | 11 | 52 | 2 | 14729963 | |
| Pubmed | 1.25e-04 | 754 | 52 | 7 | 35906200 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.31e-04 | 1024 | 52 | 8 | 24711643 | |
| Pubmed | 1.38e-04 | 332 | 52 | 5 | 25693804 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.38e-04 | 332 | 52 | 5 | 32786267 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.41e-04 | 533 | 52 | 6 | 30554943 | |
| Pubmed | CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity. | 1.43e-04 | 12 | 52 | 2 | 27140400 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.57e-04 | 341 | 52 | 5 | 32971831 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.62e-04 | 1353 | 52 | 9 | 29467282 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.91e-04 | 1082 | 52 | 8 | 38697112 | |
| Pubmed | 1.92e-04 | 808 | 52 | 7 | 20412781 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.09e-04 | 363 | 52 | 5 | 14691545 | |
| Pubmed | 2.10e-04 | 195 | 52 | 4 | 19454010 | ||
| Pubmed | 2.70e-04 | 1139 | 52 | 8 | 36417873 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.82e-04 | 861 | 52 | 7 | 36931259 | |
| Pubmed | 3.05e-04 | 215 | 52 | 4 | 30462309 | ||
| Pubmed | 3.05e-04 | 215 | 52 | 4 | 35973513 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 3.29e-04 | 1489 | 52 | 9 | 28611215 | |
| Pubmed | 3.30e-04 | 18 | 52 | 2 | 37321992 | ||
| Pubmed | LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. | 3.30e-04 | 18 | 52 | 2 | 19497860 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.70e-04 | 411 | 52 | 5 | 35182466 | |
| Pubmed | 4.00e-04 | 418 | 52 | 5 | 34709266 | ||
| Pubmed | 4.13e-04 | 233 | 52 | 4 | 29518331 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 4.61e-04 | 665 | 52 | 6 | 30457570 | |
| Pubmed | 4.74e-04 | 101 | 52 | 3 | 26949739 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 4.74e-04 | 101 | 52 | 3 | 24613305 | |
| Pubmed | 4.91e-04 | 244 | 52 | 4 | 29884807 | ||
| Pubmed | 4.94e-04 | 1247 | 52 | 8 | 27684187 | ||
| Pubmed | 5.02e-04 | 103 | 52 | 3 | 32744500 | ||
| Pubmed | 5.07e-04 | 246 | 52 | 4 | 15345747 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 5.21e-04 | 1257 | 52 | 8 | 36526897 | |
| Pubmed | 5.46e-04 | 106 | 52 | 3 | 19394292 | ||
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 6.14e-04 | 259 | 52 | 4 | 30404004 | |
| Pubmed | 6.40e-04 | 708 | 52 | 6 | 39231216 | ||
| Pubmed | 6.43e-04 | 25 | 52 | 2 | 32266943 | ||
| Pubmed | Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit. | 6.43e-04 | 25 | 52 | 2 | 28923932 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 6.46e-04 | 989 | 52 | 7 | 36424410 | |
| Pubmed | 6.51e-04 | 263 | 52 | 4 | 34702444 | ||
| Pubmed | 6.74e-04 | 114 | 52 | 3 | 31553912 | ||
| Pubmed | 6.93e-04 | 472 | 52 | 5 | 38943005 | ||
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 7.08e-04 | 269 | 52 | 4 | 30442662 | |
| Pubmed | 7.09e-04 | 116 | 52 | 3 | 21549307 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 7.19e-04 | 724 | 52 | 6 | 36232890 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 7.27e-04 | 477 | 52 | 5 | 31300519 | |
| Pubmed | 7.43e-04 | 1327 | 52 | 8 | 32694731 | ||
| Pubmed | 7.64e-04 | 119 | 52 | 3 | 23508102 | ||
| Pubmed | 7.67e-04 | 733 | 52 | 6 | 34672954 | ||
| Pubmed | 8.02e-04 | 121 | 52 | 3 | 22412018 | ||
| Pubmed | 8.08e-04 | 28 | 52 | 2 | 24448406 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 8.55e-04 | 283 | 52 | 4 | 30585729 | |
| Pubmed | 8.67e-04 | 29 | 52 | 2 | 7789972 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 8.87e-04 | 754 | 52 | 6 | 33060197 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 9.01e-04 | 1367 | 52 | 8 | 32687490 | |
| Pubmed | 9.21e-04 | 503 | 52 | 5 | 16964243 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 9.24e-04 | 289 | 52 | 4 | 23752268 | |
| Pubmed | 9.46e-04 | 506 | 52 | 5 | 30890647 | ||
| Pubmed | 9.86e-04 | 130 | 52 | 3 | 28705898 | ||
| Interaction | SMC5 interactions | ZC3H14 NCOA6 ZNF609 MAP7D3 PNN CD2AP MDC1 HMGXB4 SAFB2 SLX4IP CHD4 ZC3H18 TOR1AIP1 SON | 1.51e-07 | 1000 | 52 | 14 | int:SMC5 |
| Interaction | SNIP1 interactions | 1.07e-06 | 417 | 52 | 9 | int:SNIP1 | |
| Interaction | NKAP interactions | 1.12e-06 | 132 | 52 | 6 | int:NKAP | |
| Interaction | ZC3H11A interactions | 1.27e-06 | 215 | 52 | 7 | int:ZC3H11A | |
| Interaction | CSNK2A1 interactions | MYCN PNN CD2AP MDC1 OGDHL SLBP CHD4 ZC3H18 NKTR CDC14B TOR1AIP1 DMAP1 | 4.31e-06 | 956 | 52 | 12 | int:CSNK2A1 |
| Interaction | SNRNP40 interactions | 4.43e-06 | 637 | 52 | 10 | int:SNRNP40 | |
| Interaction | MKI67 interactions | 5.15e-06 | 648 | 52 | 10 | int:MKI67 | |
| Interaction | MEN1 interactions | ZC3H14 NCOA6 ZNF609 PNN MDC1 UBR4 SAFB2 CHD4 ZC3H18 TOR1AIP1 DMAP1 SON | 9.13e-06 | 1029 | 52 | 12 | int:MEN1 |
| Interaction | DHX8 interactions | 9.55e-06 | 292 | 52 | 7 | int:DHX8 | |
| Interaction | TERF2IP interactions | ZC3H14 NCOA6 ZNF609 MDC1 HMGXB4 SLX4IP ZC3H18 TOR1AIP1 DMAP1 | 1.05e-05 | 552 | 52 | 9 | int:TERF2IP |
| Interaction | SRSF4 interactions | 1.14e-05 | 300 | 52 | 7 | int:SRSF4 | |
| Interaction | SAP18 interactions | 1.27e-05 | 305 | 52 | 7 | int:SAP18 | |
| Interaction | ZNF543 interactions | 2.09e-05 | 21 | 52 | 3 | int:ZNF543 | |
| Interaction | CCDC85A interactions | 2.37e-05 | 65 | 52 | 4 | int:CCDC85A | |
| Interaction | MYCN interactions | MYCN ZC3H14 ZNF609 TCF12 PNN HMGXB4 SAFB2 SLBP AKAP13 CHD4 ZC3H18 UQCRFS1P1 SON | 3.34e-05 | 1373 | 52 | 13 | int:MYCN |
| Interaction | DOT1L interactions | 3.44e-05 | 807 | 52 | 10 | int:DOT1L | |
| Interaction | BRD3 interactions | 3.59e-05 | 494 | 52 | 8 | int:BRD3 | |
| Interaction | SRSF6 interactions | 4.08e-05 | 503 | 52 | 8 | int:SRSF6 | |
| Interaction | SNRPB interactions | 4.96e-05 | 517 | 52 | 8 | int:SNRPB | |
| Interaction | CPSF6 interactions | 5.59e-05 | 526 | 52 | 8 | int:CPSF6 | |
| Interaction | RBM39 interactions | 5.73e-05 | 1042 | 52 | 11 | int:RBM39 | |
| Interaction | NKAPD1 interactions | 5.87e-05 | 161 | 52 | 5 | int:NKAPD1 | |
| Interaction | CCDC9 interactions | 7.83e-05 | 88 | 52 | 4 | int:CCDC9 | |
| Interaction | IFI16 interactions | 7.85e-05 | 714 | 52 | 9 | int:IFI16 | |
| Interaction | SRPK2 interactions | 8.11e-05 | 717 | 52 | 9 | int:SRPK2 | |
| Interaction | NKTR interactions | 8.55e-05 | 90 | 52 | 4 | int:NKTR | |
| Interaction | CRNKL1 interactions | 9.19e-05 | 177 | 52 | 5 | int:CRNKL1 | |
| Interaction | HMGA1 interactions | 9.53e-05 | 419 | 52 | 7 | int:HMGA1 | |
| Interaction | HNRNPUL2 interactions | 1.00e-04 | 291 | 52 | 6 | int:HNRNPUL2 | |
| Interaction | PPP1CC interactions | 1.01e-04 | 738 | 52 | 9 | int:PPP1CC | |
| Interaction | SRSF7 interactions | 1.04e-04 | 425 | 52 | 7 | int:SRSF7 | |
| Interaction | SFSWAP interactions | 1.10e-04 | 96 | 52 | 4 | int:SFSWAP | |
| Interaction | ELAVL2 interactions | 1.22e-04 | 188 | 52 | 5 | int:ELAVL2 | |
| Interaction | PNN interactions | 1.23e-04 | 302 | 52 | 6 | int:PNN | |
| Interaction | C2orf49 interactions | 1.28e-04 | 38 | 52 | 3 | int:C2orf49 | |
| Interaction | SNRPC interactions | 1.29e-04 | 440 | 52 | 7 | int:SNRPC | |
| Interaction | THRAP3 interactions | 1.35e-04 | 443 | 52 | 7 | int:THRAP3 | |
| Interaction | CSHL1 interactions | 1.36e-04 | 7 | 52 | 2 | int:CSHL1 | |
| Interaction | CLK2 interactions | 1.45e-04 | 195 | 52 | 5 | int:CLK2 | |
| Interaction | ZBTB2 interactions | 1.48e-04 | 450 | 52 | 7 | int:ZBTB2 | |
| Interaction | PRPF19 interactions | 1.48e-04 | 450 | 52 | 7 | int:PRPF19 | |
| Interaction | BACC1 interactions | 1.50e-04 | 104 | 52 | 4 | int:BACC1 | |
| Interaction | SRSF11 interactions | 1.75e-04 | 203 | 52 | 5 | int:SRSF11 | |
| Interaction | SNRNP70 interactions | 1.79e-04 | 984 | 52 | 10 | int:SNRNP70 | |
| Interaction | DELE1 interactions | 1.81e-04 | 8 | 52 | 2 | int:DELE1 | |
| Interaction | PSIP1 interactions | 1.83e-04 | 205 | 52 | 5 | int:PSIP1 | |
| Interaction | NUP43 interactions | 1.85e-04 | 625 | 52 | 8 | int:NUP43 | |
| Interaction | NUMA1 interactions | 1.91e-04 | 469 | 52 | 7 | int:NUMA1 | |
| Interaction | ZNF207 interactions | 1.92e-04 | 111 | 52 | 4 | int:ZNF207 | |
| Interaction | SF3A1 interactions | 1.96e-04 | 471 | 52 | 7 | int:SF3A1 | |
| Interaction | DDX23 interactions | 2.20e-04 | 480 | 52 | 7 | int:DDX23 | |
| Interaction | SNRPA interactions | 2.26e-04 | 482 | 52 | 7 | int:SNRPA | |
| Interaction | SUZ12 interactions | 2.26e-04 | 644 | 52 | 8 | int:SUZ12 | |
| Interaction | BUD31 interactions | 2.28e-04 | 116 | 52 | 4 | int:BUD31 | |
| Interaction | IK interactions | 2.28e-04 | 215 | 52 | 5 | int:IK | |
| Interaction | RBBP6 interactions | 2.33e-04 | 216 | 52 | 5 | int:RBBP6 | |
| Interaction | HMGB1 interactions | 2.38e-04 | 486 | 52 | 7 | int:HMGB1 | |
| Interaction | RBM17 interactions | 2.43e-04 | 218 | 52 | 5 | int:RBM17 | |
| Interaction | CAMKV interactions | 2.43e-04 | 118 | 52 | 4 | int:CAMKV | |
| Interaction | CALM3 interactions | 2.45e-04 | 343 | 52 | 6 | int:CALM3 | |
| Interaction | SRRM1 interactions | 2.65e-04 | 348 | 52 | 6 | int:SRRM1 | |
| Interaction | SRSF9 interactions | 2.76e-04 | 224 | 52 | 5 | int:SRSF9 | |
| Interaction | CUL7 interactions | 2.79e-04 | 845 | 52 | 9 | int:CUL7 | |
| Interaction | EIF4A3 interactions | 2.79e-04 | 499 | 52 | 7 | int:EIF4A3 | |
| Interaction | FOXK2 interactions | 2.81e-04 | 225 | 52 | 5 | int:FOXK2 | |
| Interaction | YWHAG interactions | MYCN NCOA6 ABLIM1 MAP7D3 BRAF PNN CD2AP AKAP13 NKTR MDM4 SON | 2.82e-04 | 1248 | 52 | 11 | int:YWHAG |
| Interaction | PAGR1 interactions | 3.09e-04 | 51 | 52 | 3 | int:PAGR1 | |
| Interaction | CD2BP2 interactions | 3.24e-04 | 232 | 52 | 5 | int:CD2BP2 | |
| Interaction | RNF2 interactions | 3.34e-04 | 866 | 52 | 9 | int:RNF2 | |
| Interaction | SSRP1 interactions | 3.43e-04 | 685 | 52 | 8 | int:SSRP1 | |
| Interaction | ZCCHC10 interactions | 3.50e-04 | 236 | 52 | 5 | int:ZCCHC10 | |
| Interaction | SFN interactions | 3.67e-04 | 692 | 52 | 8 | int:SFN | |
| Interaction | HNRNPAB interactions | 3.72e-04 | 371 | 52 | 6 | int:HNRNPAB | |
| Interaction | PPP1CA interactions | 3.82e-04 | 696 | 52 | 8 | int:PPP1CA | |
| Interaction | TOP1 interactions | 3.82e-04 | 696 | 52 | 8 | int:TOP1 | |
| Interaction | SH3BP1 interactions | 3.87e-04 | 55 | 52 | 3 | int:SH3BP1 | |
| Interaction | LUC7L interactions | 3.93e-04 | 242 | 52 | 5 | int:LUC7L | |
| Interaction | TPRX2 interactions | 4.08e-04 | 56 | 52 | 3 | int:TPRX2 | |
| Interaction | SAFB interactions | 4.08e-04 | 244 | 52 | 5 | int:SAFB | |
| Interaction | YAP1 interactions | 4.22e-04 | 1095 | 52 | 10 | int:YAP1 | |
| Interaction | YWHAH interactions | 4.44e-04 | 1102 | 52 | 10 | int:YWHAH | |
| Interaction | SNRPF interactions | 4.53e-04 | 385 | 52 | 6 | int:SNRPF | |
| Interaction | MAD2L1 interactions | 4.73e-04 | 252 | 52 | 5 | int:MAD2L1 | |
| Interaction | CWC22 interactions | 4.79e-04 | 141 | 52 | 4 | int:CWC22 | |
| Interaction | SUDS3 interactions | 4.79e-04 | 141 | 52 | 4 | int:SUDS3 | |
| Interaction | HNRNPM interactions | 4.91e-04 | 723 | 52 | 8 | int:HNRNPM | |
| Interaction | PABPC5 interactions | 4.92e-04 | 142 | 52 | 4 | int:PABPC5 | |
| Interaction | PES1 interactions | 5.26e-04 | 258 | 52 | 5 | int:PES1 | |
| Interaction | DYNLL2 interactions | 5.74e-04 | 263 | 52 | 5 | int:DYNLL2 | |
| Interaction | PML interactions | 5.75e-04 | 933 | 52 | 9 | int:PML | |
| Interaction | ISG20L2 interactions | 5.77e-04 | 63 | 52 | 3 | int:ISG20L2 | |
| Interaction | TAF15 interactions | 6.15e-04 | 408 | 52 | 6 | int:TAF15 | |
| Interaction | NCBP3 interactions | 7.01e-04 | 156 | 52 | 4 | int:NCBP3 | |
| Interaction | EP300 interactions | 7.52e-04 | 1401 | 52 | 11 | int:EP300 | |
| Interaction | RNPS1 interactions | 7.61e-04 | 425 | 52 | 6 | int:RNPS1 | |
| Interaction | ZNF816 interactions | 7.66e-04 | 16 | 52 | 2 | int:ZNF816 | |
| Interaction | SUMO2 interactions | 7.66e-04 | 591 | 52 | 7 | int:SUMO2 | |
| Interaction | WBP11 interactions | 7.70e-04 | 160 | 52 | 4 | int:WBP11 | |
| Interaction | BRD2 interactions | 7.99e-04 | 429 | 52 | 6 | int:BRD2 | |
| Interaction | NAA40 interactions | 8.06e-04 | 978 | 52 | 9 | int:NAA40 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | JPH1 NCOA6 PNN SWT1 STXBP5L PCLO ASPM SAFB2 NKTR TMEM43 ZMYM5 | 4.29e-06 | 831 | 52 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | 1.27e-04 | 994 | 52 | 10 | Facebase_RNAseq_e8.5_Floor Plate_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NCOA6 TCF12 ANK2 PNN ARVCF SWT1 MDC1 TTC14 ASPM CHD4 DCUN1D4 ZMYM5 | 1.66e-04 | 1459 | 52 | 12 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NCOA6 TCF12 ANK2 PNN SWT1 MDC1 TTC14 ASPM CHD4 DCUN1D4 ZMYM5 | 1.91e-04 | 1257 | 52 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | 1.94e-04 | 495 | 52 | 7 | Facebase_RNAseq_e8.5_Floor Plate_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.01e-04 | 498 | 52 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.19e-07 | 199 | 52 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.99e-07 | 147 | 52 | 5 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 188 | 52 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 193 | 52 | 5 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 193 | 52 | 5 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.12e-06 | 194 | 52 | 5 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 3.12e-06 | 194 | 52 | 5 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 195 | 52 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.20e-06 | 195 | 52 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 195 | 52 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.62e-06 | 200 | 52 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.62e-06 | 200 | 52 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 3.65e-05 | 160 | 52 | 4 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 3.74e-05 | 161 | 52 | 4 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 166 | 52 | 4 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 5.53e-05 | 178 | 52 | 4 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.65e-05 | 179 | 52 | 4 | f2e8fc975c30992611630197b79daaeef7c4211d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.90e-05 | 181 | 52 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 184 | 52 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 184 | 52 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 184 | 52 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.29e-05 | 184 | 52 | 4 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.42e-05 | 185 | 52 | 4 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.69e-05 | 187 | 52 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.83e-05 | 188 | 52 | 4 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.98e-05 | 189 | 52 | 4 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.12e-05 | 190 | 52 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.12e-05 | 190 | 52 | 4 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.41e-05 | 192 | 52 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.56e-05 | 193 | 52 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | remission|World / disease stage, cell group and cell class | 7.56e-05 | 193 | 52 | 4 | 86cfd0c230ba96a43d343216935952fff6a5254e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.56e-05 | 193 | 52 | 4 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 194 | 52 | 4 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-05 | 196 | 52 | 4 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 8.19e-05 | 197 | 52 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 8.19e-05 | 197 | 52 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.35e-05 | 198 | 52 | 4 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.35e-05 | 198 | 52 | 4 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.35e-05 | 198 | 52 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.35e-05 | 198 | 52 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 8.51e-05 | 199 | 52 | 4 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 8.51e-05 | 199 | 52 | 4 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 8.68e-05 | 200 | 52 | 4 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 8.68e-05 | 200 | 52 | 4 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.58e-07 | 178 | 52 | 7 | 3998_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.29e-07 | 188 | 52 | 7 | 6735_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.93e-07 | 195 | 52 | 7 | 1080_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.48e-06 | 189 | 52 | 6 | 1045_DN | |
| Drug | Isoammodendrine | 5.12e-06 | 2 | 52 | 2 | CID000108191 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 5.19e-05 | 177 | 52 | 5 | 985_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 5.47e-05 | 179 | 52 | 5 | 4585_DN | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A | 7.82e-05 | 193 | 52 | 5 | 6920_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 7.82e-05 | 193 | 52 | 5 | 5268_UP | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 4599_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 3705_DN | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 4748_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 3812_DN | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 4766_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 2898_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 1482_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 4492_UP | |
| Drug | Diflunisal [22494-42-4]; Up 200; 16uM; PC3; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 4210_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 5283_DN | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.25e-05 | 200 | 52 | 5 | 1476_DN | |
| Disease | intellectual disability (implicated_via_orthology) | 2.67e-04 | 75 | 49 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 6.21e-04 | 100 | 49 | 3 | C0010606 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 1.46e-03 | 34 | 49 | 2 | DOID:9952 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ETVPKVTSRSRSKTS | 176 | Q5RHP9 | |
| STRIKTEEEAFSSKR | 91 | Q92564 | |
| RKSSSSSEDRNRMKT | 426 | P15056 | |
| TSEDGTTRRTETKVT | 111 | O00192 | |
| SEKSKVTSSERTSAR | 16 | O14639 | |
| ITKRTTRSASRKSSV | 471 | O60729 | |
| TRSASRKSSVKSLSI | 476 | O60729 | |
| STEKTAETETSRSRE | 561 | Q12802 | |
| RTKSTSDNETSRKNE | 41 | O60359 | |
| KEGSVKLRTRTSSSE | 221 | Q9Y5K6 | |
| RSDEAQRVFKSSKTS | 306 | P42081 | |
| STTASVARKRKSDGS | 566 | Q8IZT6 | |
| VLVTSESRKVSSSSE | 2651 | Q01484 | |
| SERRMVKKSRTTSSS | 176 | Q14676 | |
| LKQSAEESSTSRKRT | 136 | O15151 | |
| DLSKSSSVTVRSRKT | 2036 | Q5SZK8 | |
| SESKSSISSKRSSVR | 226 | Q9HDC5 | |
| SKSRTTDTFRSEQKL | 111 | Q9Y6V0 | |
| RRRTKKSVDTSVQTD | 3461 | Q9Y6V0 | |
| KNSRSDRKRSISESS | 681 | Q9H307 | |
| ESRSAVSSRTKTSKL | 96 | Q9ULD0 | |
| QKDIKVSSRGRTSST | 546 | Q99081 | |
| EATTVKRKASSSEGS | 471 | Q9UGU5 | |
| RERTYSTVKTKSTSA | 486 | Q15375 | |
| GLSSESSRKTKSTEE | 201 | Q8N5Z5 | |
| SSTKDITSAVQSKRR | 2046 | Q14686 | |
| TKRTLSETSSSKSFE | 491 | Q14721 | |
| RRESASSSSSVKKAK | 451 | Q9NPF5 | |
| SGAEKATTRRKASST | 1291 | Q7Z591 | |
| KEKVTSGSTTTTRRS | 446 | P02671 | |
| TTRRSCSKTVTKTVI | 456 | P02671 | |
| KTRKADETNTTSRSS | 841 | Q8IWC1 | |
| TKSNIKRTSSSERVS | 126 | O00423 | |
| RKRKSDVSSSTASLA | 216 | Q12951 | |
| KSLSRVAKETSESTR | 641 | A6NE01 | |
| VSDGSTSRSSRSRKK | 331 | Q14839 | |
| SSTSTRREHVKVKTS | 6 | Q9BTV4 | |
| RERKSSSGSSDSKES | 106 | Q14493 | |
| ESSKSSTRRMKSSCD | 466 | P30414 | |
| SRSPSRSRSKSETKS | 1311 | P30414 | |
| SSSSIRSVSSEKRKL | 41 | Q5T5J6 | |
| SRSSSISSIDKDSKE | 816 | Q9Y2K9 | |
| KSSVTSKSQTRRDTV | 176 | Q5VYV7 | |
| SKSQTRRDTVETSSD | 181 | Q5VYV7 | |
| TKEQSDVTTSERTRS | 161 | Q5U649 | |
| SVTTVKARSRDSDES | 231 | Q5JTV8 | |
| TVEKRRSSSNTKAVT | 281 | P04198 | |
| PSRVSTDTRTSKASK | 91 | B3KS81 | |
| TDTRTSKASKASDVR | 96 | B3KS81 | |
| NSSSEDSKGSKRVRT | 451 | O15014 | |
| KRRKSTSSSSVSSAD | 471 | Q96N46 | |
| KTTSRSKERSSKSQD | 586 | Q14151 | |
| STSSLSRSKTKTGVR | 156 | Q9UJ78 | |
| LDSTKSSRESTEARK | 106 | P0C7P4 | |
| KRKTATITTRTSSQV | 2271 | Q5T4S7 | |
| KRDSRVSTSSQESKT | 126 | Q6PJT7 | |
| SSEHKSRKRTSESRS | 1831 | P18583 | |
| STKSGKASTLSRREE | 916 | Q86VM9 |